tiprankstipranks
Sangui BioTech International Inc (SGBI)
OTHER OTC:SGBI
Holding SGBI?
Track your performance easily

Sangui BioTech International (SGBI) Income Statement

3 Followers

Sangui BioTech International Income Statement

Last quarter (Q3 2023), Sangui BioTech International's total revenue was $18.70K, an increase of 4.14% from the same quarter last year. In Q3, Sangui BioTech International's net income was $-38.19K. See Sangui BioTech International’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 22Jun 21Jun 20Jun 19Jun 18
Total Revenue
$ 80.86K$ 69.19K$ 65.58K$ 28.91K$ 88.00K$ 77.15K
Cost of Revenue
-----$ -62.00
Gross Profit
$ 80.86K$ 69.19K$ 65.58K$ 28.91K$ 88.00K$ 77.09K
Operating Expense
$ 195.16K$ 208.64K$ 216.72K$ 210.31K$ -425.64K$ -285.13K
Operating Income
$ -114.30K$ -139.45K$ -151.14K$ -181.39K$ -337.63K$ -208.04K
Net Non Operating Interest Income Expense
$ -20.72K$ -23.62K$ -17.99K$ -14.10K$ -11.69K$ -8.31K
Other Income Expense
$ -48.65K--$ 6.71K--
Pretax Income
$ -126.66K$ -63.34K$ -203.71K$ -198.53K$ -342.51K$ -215.80K
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -216.26K$ -130.72K$ -198.89K$ -192.74K$ -703.97K$ -445.60K
Basic EPS
------
Diluted EPS
------
Basic Average Shares
--$ 204.19M$ 201.75M$ 197.13M$ 188.20M
Diluted Average Shares
--$ 204.19M$ 201.75M--
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 195.16K$ 208.64K$ 216.72K$ 210.31K$ -425.64K$ -285.20K
Net Income From Continuing And Discontinued Operation
$ -126.38K$ -63.34K$ -198.89K$ -192.74K$ -703.97K$ -445.60K
Normalized Income
--$ -160.93K---
Interest Expense
------
EBIT
$ -105.94K$ -43.98K$ -185.72K$ -184.43K$ -330.83K$ -207.50K
EBITDA
$ -57.37K$ -22.48K$ -165.24K$ -183.22K$ -330.83K$ -207.50K
Currency in USD

Sangui BioTech International Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis